The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-20 of 43 articles
Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable-polymer coronary stent – five-year results of the TARGET All Comers randomised clinical trial
Lansky AJ,
Xu B,
Baumbach A,
Kelbæk H,
van Royen N,
Zheng M,
Knaapen P,
Slagboom T,
Johnson TW,
Vlachojannis GJ,
Arkenbout KE,
Holmvang L,
Janssens L,
Brugaletta S,
Naber C,
Schmitz T,
Anderson R,
Rittger H,
Berti S,
Barbato E,
Toth GG,
Maillard L,
Valina CM,
Buszman PE,
Thiele H,
Schächinger V,
Wijns W
October 20, 2023 | 10.4244/EIJ-D-23-00409
Cerebral embolic protection during transcatheter heart interventions
September 18, 2023 | 10.4244/EIJ-D-23-00166
Revascularisation, periprocedural events and survival – and the survival of the randomised controlled trial
March 20, 2023 | 10.4244/EIJ-E-23-00004
Safety and performance of a novel cerebral embolic protection device for transcatheter aortic valve implantation: the PROTEMBO C Trial
Jagielak D,
Targonski R,
Frerker C,
Abdel-Wahab M,
Wilde J,
Werner N,
Lauterbach M,
Leick J,
Grygier M,
Misterski M,
Erglis A,
Narbute I,
Witkowski A,
Adam M,
Frank D,
Gatto F,
Schmidt T,
Lansky AJ
September 20, 2022 | 10.4244/EIJ-D-22-00238
Abluminal groove-filled biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent: three-year results of the TARGET All Comers trial
Saito Y,
Kelbæk H,
Xu B,
Hussain Y,
Anderson R,
Schächinger V,
Zheng M,
Wijns W,
Baumbach A,
Lansky AJ
July 20, 2021 | 10.4244/EIJ-D-20-00344
An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group
Kunadian V,
Chieffo A,
Camici P,
Berry C,
Escaned J,
Maas A,
Prescott E,
Karam N,
Appelman Y,
Fraccaro C,
Buchanan G,
Manzo-Silberman S,
Al-Lamee R,
Regar E,
Lansky AJ,
Abbott J,
Badimon L,
Duncker D,
Mehran R,
Capodanno D,
Baumbach A
January 20, 2021 | 10.4244/EIJY20M07_01
Management of myocardial revascularisation failure: an expert consensus document of the EAPCI
Stefanini G,
Alfonso F,
Barbato E,
Byrne RA,
Capodanno D,
Colleran R,
Escaned J,
Giacoppo D,
Kunadian V,
Lansky AJ,
Mehilli J,
Neumann F,
Regazzoli D,
Sanchez J,
Wijns W,
Baumbach A
December 4, 2020 | 10.4244/EIJ-D-20-00487
Immediate and long-term impact of the COVID-19 pandemic on cardiovascular clinical trials: considerations for study conduct and endpoint determination
Lansky AJ,
Shah T,
Wijns W,
Stefanini G,
Farb A,
Kaplan A,
Xu B,
Pietras C,
Velazquez E,
Serruys PW,
Mahfoud F,
Baumbach A
November 20, 2020 | 10.4244/EIJV16I10A147
A pilot study with the TriGUARD 3 cerebral embolic protection device
August 7, 2020 | 10.4244/EIJ-D-19-00741
Clinical outcome after interventions with paclitaxel-coated balloons: a PCR statement
Lansky AJ,
Cremonesi A,
Scheller B,
James S,
Grubman D,
Fajadet J,
Sauguet A,
Micari A,
Sarno G,
Bosiers M,
Baumbach A,
Wijns W
February 20, 2020 | 10.4244/EIJV15I14A220
Defining device success for percutaneous coronary intervention trials: a position statement from the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology
Chang C,
Kogame N,
Onuma Y,
Byrne RA,
Capodanno D,
Windecker S,
Morel M,
Cutlip D,
Krucoff M,
Stone GW,
Lansky AJ,
Mehran R,
Spitzer E,
Fraser A,
Baumbach A,
Serruys PW
January 17, 2020 | 10.4244/EIJ-D-19-00552
Optical coherence tomography substudy of a prospective multicentre randomised post-market trial to assess the safety and effectiveness of the Firehawk cobalt-chromium coronary stent (rapamycin target-eluting) system for the treatment of atherosclerotic lesions: TARGET All Comers
Baumbach A,
Lansky AJ,
Onuma Y,
Asano T,
Johnson TW,
Anderson R,
Kiemeneij F,
Zeng M,
van Royen N,
Slagboom T,
Vlachojannis GJ,
Serruys PW,
Wijns W
November 20, 2018 | 10.4244/EIJ-D-18-00226
TAVI and the brain: update on definitions, evidence of neuroprotection and adjunctive pharmacotherapy
September 7, 2018 | 10.4244/EIJ-D-18-00454
Acute and one-year clinical outcomes following implantation of bioresorbable vascular scaffolds: the ABSORB UK Registry
Baumbach A,
Zaman A,
West N,
O'Kane P,
Egred M,
Johnson TW,
Wheatcroft S,
Bowles R,
de Belder A,
Bouras G,
Lansky AJ,
Hill J,
Mathur A,
De Belder M,
Banning AP
January 19, 2018 | 10.4244/EIJ-D-17-00886
EXCEL and NOBLE: stents or surgery for left main stem stenosis?
August 4, 2017 | 10.4244/EIJV13I5A94
Will PIONEER AF-PCI change my practice?
August 4, 2017 | 10.4244/EIJV13I5A95
The SURTAVI study: TAVI for patients with intermediate risk
August 4, 2017 | 10.4244/EIJV13I5A97
Quantitative angiography methods for bifurcation lesions: a consensus statement update from the European Bifurcation Club
Collet C,
Onuma Y,
Cavalcante R,
Grundeken M.J,
Généreux P,
Popma J,
Costa R,
Stankovic G,
Tu S,
Reiber J,
Aben J,
Lassen JF,
Louvard Y,
Lansky AJ,
Serruys PW
May 15, 2017 | 10.4244/EIJ-D-16-00932
Embolic protection devices in transcatheter aortic valve implantation
May 3, 2017 | 10.4244/EIJV11I2A45
Latest news
AHEAD OF PRINT
Robotic-assisted CABG: clinical outcomes
FREE ARTICLE - Aleksander Dokollari et al
November 23, 2023
PCR London Valves 2023
November 16, 2023
NEW ISSUE
PCR London Valves special edition. State-of-the-art on TMVI; the timing of TMVI; direct wire pacing for TMVR; predicting patient-prosthesis mismatch following TAVI and more
November 17, 2023
AHEAD OF PRINT
Pathophysiological CAD patterns predict outcomes post-PCI
FREE ARTICLE - Nozomi Kotoku et al
November 14, 2023
AHEAD OF PRINT
Cardiac damage classification in each AS subtype
FREE ARTICLE - Masaaki Nakase et al
November 6, 2023
AHEAD OF PRINT
Extra-mitral valve cardiac involvement in MR
FREE ARTICLE - Antonio Popolo Rubbio et al
November 9, 2023
AHEAD OF PRINT
CAPTIS embolic protection during TAVR
FREE ARTICLE - Haim D. Danenberg et al
November 2, 2023